- (a) A pharmaceutical drug manufacturer shall submit a fee in the amount provided by department rule with each report submitted under this subchapter.
- (b) The executive commissioner by rule shall set the fee in the amount necessary for the department to administer this chapter, not to exceed $400.
Added by Acts 2021, 87th Leg., R.S., Ch. 50 (H.B. 1033), Sec. 4, eff. September 1, 2021.